Comparing Keppra vs Lacosamide
| Keppra (levetiracetam) | Lacosamide |
|
|---|
| Keppra (levetiracetam) | Lacosamide |
|
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Keppra is an anticonvulsant used to treat partial onset, myoclonic, or generalized tonic-clonic seizures, either alone or in combination with other anticonvulsants. It may cause drowsiness but is... View more |
Prescription only
Prescribed for Epilepsy, Seizures. Lacosamide may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||||||||||||||
| More about Keppra (levetiracetam) | More about Lacosamide | ||||||||||||||||||||
| Ratings & Reviews | |||||||||||||||||||||
|
Keppra has an average rating of 5.7 out of 10 from a total of 318 ratings on Drugs.com. 43% of reviewers reported a positive effect, while 34% reported a negative effect. |
Lacosamide has an average rating of 6.7 out of 10 from a total of 185 ratings on Drugs.com. 52% of reviewers reported a positive effect, while 20% reported a negative effect. |
||||||||||||||||||||
|
View all 318 reviews |
View all 185 reviews |
||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||||||
View all side effects |
View all side effects |
||||||||||||||||||||
| Boxed Warnings A boxed warning is the most serious warning from the Food and Drug Administration (FDA) about drug effects that may be dangerous. | |||||||||||||||||||||
|
N/A |
N/A |
||||||||||||||||||||
| Drug Class | |||||||||||||||||||||
| Generic Availability Learn more about brand vs generic drugs. | |||||||||||||||||||||
|
Lower cost generic |
|||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance. | |||||||||||||||||||||
|
|
||||||||||||||||||||
| Dosage Forms | |||||||||||||||||||||
|
|
||||||||||||||||||||
| Brand Names | |||||||||||||||||||||
| Other levetiracetam brands include: Elepsia XR, Keppra XR, Roweepra, Roweepra XR, Spritam | Motpoly XR, Vimpat | ||||||||||||||||||||
| Half Life Learn about the half-life of a drug and how it is calculated. | |||||||||||||||||||||
|
8 hours |
13 hours |
||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Some potential for abuse
Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
||||||||||||||||||||
| Pregnancy Category | |||||||||||||||||||||
|
Category C
See the full pregnancy warnings document. |
Category C
See the full pregnancy warnings document. |
||||||||||||||||||||
| Drug Interactions | |||||||||||||||||||||
|
A total of 243 drugs are known to interact with Keppra:
|
A total of 162 drugs are known to interact with Lacosamide:
|
||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||||||
|
|
||||||||||||||||||||
| Disease Interactions | |||||||||||||||||||||
| First Approval Date | |||||||||||||||||||||
|
November 30, 1999 |
October 28, 2008 |
||||||||||||||||||||
| WADA Class View classifications | |||||||||||||||||||||
|
N/A |
N/A |
||||||||||||||||||||
| More Information | |||||||||||||||||||||
| Patient Resources | |||||||||||||||||||||
| Professional Resources | |||||||||||||||||||||
| Related Treatment Guide | |||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.